Related references
Note: Only part of the references are listed.Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy
Cheryl A. Hawkes et al.
ACTA NEUROPATHOLOGICA (2011)
Neprilysin-2 Is an Important beta-Amyloid Degrading Enzyme
Daniel Hafez et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
Bradley T. Hyman
ARCHIVES OF NEUROLOGY (2011)
Mechanism mediating oligomeric Aβ clearance by naive primary microglia
Cheng-Ning Yang et al.
NEUROBIOLOGY OF DISEASE (2011)
Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Aβ Toxicity in a Mouse Model of Alzheimer's Disease
Brian Spencer et al.
PLOS ONE (2011)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
Mechanisms of Enzymatic Degradation of Amyloid β Microfibrils Generating Nanofilaments and Nanospheres Related to Cytotoxicity
Keiji Numata et al.
BIOCHEMISTRY (2010)
Oligomeric Aβ in Alzheimer's Disease: Relationship to Plaque and Tangle Pathology, APOE Genotype and Cerebral Amyloid Angiopathy
Zoe van Helmond et al.
BRAIN PATHOLOGY (2010)
Changes with Age in the Activities of β-Secretase and the Aβ-Degrading Enzymes Neprilysin, Insulin-Degrading Enzyme and Angiotensin-Converting Enzyme
J. Scott Miners et al.
BRAIN PATHOLOGY (2010)
Plasminogen and plasmin in Alzheimer's disease
Rachel Barker et al.
BRAIN RESEARCH (2010)
Expression of Somatostatin, Cortistatin, and Their Receptors, as well as Dopamine Receptors, but not of Neprilysin, are Reduced in the Temporal Lobe of Alzheimer's Disease Patients
Manuel D. Gahete et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Insulin-Degrading Enzyme Sorting in Exosomes: A Secretory Pathway for a Key Brain Amyloid-beta Degrading Protease
Ayelen Bulloj et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls
Johan Sundelof et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Estrogen Stimulates Degradation of β-Amyloid Peptide by Up-regulating Neprilysin
Kaiwei Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion
Irfan Y. Tamboli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Matrix Metalloproteinase 2 (MMP-2) Degrades Soluble Vasculotropic Amyloid-β E22Q and L34V Mutants, Delaying Their Toxicity for Human Brain Microvascular Endothelial Cells
Mar Hernandez-Guillamon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Gene therapy in Alzheimer's disease - potential for disease modification
Per Nilsson et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Stem cells in human neurodegenerative disorders - time for clinical translation?
Olle Lindvall et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The role of microglia in amyloid clearance from the AD brain
C. Y. Daniel Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain
Suqing Wang et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice
Lori Lebson et al.
JOURNAL OF NEUROSCIENCE (2010)
Norepinephrine Promotes Microglia to Uptake and Degrade Amyloid β Peptide through Upregulation of Mouse Formyl Peptide Receptor 2 and Induction of Insulin-Degrading Enzyme
Yan Kong et al.
JOURNAL OF NEUROSCIENCE (2010)
Circulating neprilysin clears brain amyloid
Yinxing Liu et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils
Mahiuddin Ahmed et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia
J. C. Palmer et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
Luis Escribano et al.
NEUROPSYCHOPHARMACOLOGY (2010)
MEROPS: the peptidase database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2010)
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine
Michael T. Heneka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Efficient Processing of Alzheimer's Disease Amyloid-Beta Peptides by Neuroectodermally Converted Mesenchymal Stem Cells
Hans-Joerg Habisch et al.
STEM CELLS AND DEVELOPMENT (2010)
Lymphatic drainage of the brain and the pathophysiology of neurological disease
Roy O. Weller et al.
ACTA NEUROPATHOLOGICA (2009)
Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy
Roy O. Weller et al.
ACTA NEUROPATHOLOGICA (2009)
Endothelin-Converting Enzyme-2 Is Increased in Alzheimer's Disease and Up-Regulated by Aβ
Jennifer C. Palmer et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
In vivo metabolism study of ginsenoside Re in rat using high-performance liquid chromatography coupled with tandem mass spectrometry
Liu Yang et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease
Weiming Xia et al.
ARCHIVES OF NEUROLOGY (2009)
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review
Hannah A. D. Keage et al.
BMC NEUROLOGY (2009)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease
Nikolai D. Belyaev et al.
EMBO REPORTS (2009)
Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy
Seth Love et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Effects of 4-Hydroxy-Nonenal and Amyloid-β on Expression and Activity of Endothelin Converting Enzyme and Insulin Degrading Enzyme in SH-SY5Y Cells
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Degradation of Amyloid β Protein by Purified Myelin Basic Protein
Mei-Chen Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Aβ42-to-Aβ40-and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
Kun Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The N-terminal tripeptide of insulin-like growth factor-I protects against β-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3β modulation
Emma Burgos-Ramos et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Effects of HNE-modification induced by Aβ on neprilysin expression and activity in SH-SY5Y cells
Rui Wang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Restored degradation of the Alzheimer's amyloid-β peptide by targeting amyloid formation
Peter J. Crouch et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Neprilysin and Insulin-Degrading Enzyme Levels Are Increased in Alzheimer Disease in Relation to Disease Severity
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice
William J. Meilandt et al.
JOURNAL OF NEUROSCIENCE (2009)
Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis
Shweta Mandrekar et al.
JOURNAL OF NEUROSCIENCE (2009)
Peripherally Expressed Neprilysin Reduces Brain Amyloid Burden: A Novel Approach for Treating Alzheimer's Disease
Hanjun Guan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
Rina Yamin et al.
MOLECULAR NEURODEGENERATION (2009)
Minocycline prevents Aβ(25-35)-induced reduction of somatostatin and neprilysin content in rat temporal cortex
E. Burgos-Ramos et al.
LIFE SCIENCES (2009)
Improved Learning and Memory in Aged Mice Deficient in Amyloid β-Degrading Neutral Endopeptidase
Thomas Walther et al.
PLOS ONE (2009)
Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease
Olle Lindvall et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
Roy O Weller et al.
Alzheimers Research & Therapy (2009)
Controlled dissemination of AAV vectors in the primate brain
Vanja Varenika et al.
NEUROTHERAPY: PROGRESS IN RESTORATIVE NEUROSCIENCE AND NEUROLOGY (2009)
CNS-directed gene therapy for lysosomal storage diseases
Mark S. Sands et al.
ACTA PAEDIATRICA (2008)
Neprilysin: An enzyme candidate to slow the progression of Alzheimer's disease
Salim S. El-Amouri et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice
Brian Spencer et al.
BMC NEUROSCIENCE (2008)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
The role of the cell surface LRP and soluble LRP in blood-brain barrier a clearance in Alzheimer's Disease
R. Deane et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-β peptides
Xiaoou Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Human neprilysin-2 (NEP2) and NEP display distinct subcellular localisations and substrate preferences
Alison R. Whyteside et al.
FEBS LETTERS (2008)
The AβCs of Aβ-cleaving Proteases
Malcolm A. Leissring
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Overexpression of neprilysin reduces Alzheimer amyloid-β42 (Aβ42)-induced neuron loss and intraneuronal Aβ42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila
Kanae Iijima-Ando et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1-42 by Rat Primary Type 2 Microglia
Eisuke Shimizu et al.
JOURNAL OF IMMUNOLOGY (2008)
Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice
Suzanne E. Hickman et al.
JOURNAL OF NEUROSCIENCE (2008)
Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid
James Scott Miners et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates
James Scott Miners et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Somatostatin and Alzheimer's disease
E. Burgos-Ramos et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain:: Inverse correlation with Aβ levels
E. Hellstrom-Lindahl et al.
NEUROBIOLOGY OF AGING (2008)
Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidon
Yotam Nisemblat et al.
NEURODEGENERATIVE DISEASES (2008)
MMP-2,-3 and-9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease
S. Baig et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy
J. S. Miners et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology
R. O. Carare et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40
J. Y. Huang et al.
NEUROSCIENCE (2008)
Increased expression of Aβ degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology
Saila Vepsalainen et al.
NEUROSCIENCE LETTERS (2008)
The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's A beta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Ilya Yu. Toropygin et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
Roy O. Weller et al.
BRAIN PATHOLOGY (2008)
Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid
Sandra Chimon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: The role of immunological synapses in understanding the cell biology of neuroimmune interactions
Pedro R. Lowenstein et al.
CURRENT GENE THERAPY (2007)
MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-β peptides -: Implications for the mechanisms of Aβ clearance at the blood-brain barrier
Diana Kuhnke et al.
BRAIN PATHOLOGY (2007)
Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-β-degrading enzyme neprilysin
Yvonne S. Eisele et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
Reducing amyloid plaque burden via ex vivo gene delivery of an aβ-degrading protease:: A novel therapeutic approach to Alzheimer!Disease
Matthew L. Hemming et al.
PLOS MEDICINE (2007)
Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy
Wesley Farris et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques:: Implications for Alzheimer's disease pathogenesis
Jie Zhao et al.
JOURNAL OF NEUROSCIENCE (2007)
Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils
Amitabha Majumdar et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease
Matthew L. Hemming et al.
NEUROBIOLOGY OF DISEASE (2007)
被撤回的出版物: Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer (Retracted article. See vol. 78, pg. 3397, 2018)
Sai Murali Krishna Pulukuri et al.
CANCER RESEARCH (2007)
Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease
R. R. Lonser et al.
NEUROLOGY (2007)
Histone deacetylases: Focus on the nervous system
B. E. Morrison et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-beta peptide
Rina Yamin et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Neuronal neprilysin overexpression is associated with attenuation of Aβ-related spatial memory deficit
Raphael Poirier et al.
NEUROBIOLOGY OF DISEASE (2006)
Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo
Rime Madani et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways
Anne Wisner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Aβ species removal after Aβ42 immunization
James A. R. Nicoll et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism
Ke-Jie Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
Regulation of steady-state β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme
Elizabeth A. Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic Tg2576 mice with Alzheimer pathology
Maria C. Leal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease
Sarah Mueller-Steiner et al.
NEURON (2006)
Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ
Ping Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J. Bateman et al.
NATURE MEDICINE (2006)
Neprilysin-sensitive synapse-associated amyloid-β peptide oligomers impair neuronal plasticity and cognitive function
Shu-Ming Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Amyloid β peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes
Michael Huell et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures
John A. Lynch et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity:: a potent role for trimers
M Townsend et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory
LB Zou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea
S Ayoub et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid β and impairment of learning and memory
A Mouri et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease
AR Simard et al.
NEURON (2006)
beta-amyloid degradation and Alzheimer's disease
Deng-Shun Wang et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor
ML Hemming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neprylisin decreases uniformly in Alzheimer's disease and in normal aging
R Russo et al.
FEBS LETTERS (2005)
Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen
MT Krauze et al.
EXPERIMENTAL NEUROLOGY (2005)
Metabolism of amyloid-β peptide and Alzheimer's disease
N Iwata et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Aβ-degrading enzymes:: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention
EA Eckman et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Autocatalytic cleavage of myelin basic protein: An alternative to molecular mimicry
CA D'Souza et al.
BIOCHEMISTRY (2005)
Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines
J Koenigsknecht-Talboo et al.
JOURNAL OF NEUROSCIENCE (2005)
Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia
L Morelli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain
S Love et al.
NATURE MEDICINE (2005)
Safety and feasibility of convection-enhanced delivery of cotara for the treatment of malignant glioma: Initial experience in 51 patients
SJ Patel et al.
NEUROSURGERY (2005)
Aβ(31-35) peptide induce apoptosis in PC 12 cells:: Contrast with Aβ(25-35) peptide and examination of underlying mechanisms
F Misiti et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease
M Maruyama et al.
ANNALS OF NEUROLOGY (2005)
Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP
R Pardossi-Piquard et al.
NEURON (2005)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
MH Tuszynski et al.
NATURE MEDICINE (2005)
Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation
T Saito et al.
NATURE MEDICINE (2005)
Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease
RR Lonser et al.
ANNALS OF NEUROLOGY (2005)
Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice
O Lazarov et al.
CELL (2005)
The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide
R Oba et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of β-amyloid-treated rats
D Aguado-Llera et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: An immunohistochemical analysis
U Kumar
NEUROSCIENCE (2005)
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain
MR D'Andrea et al.
NEUROBIOLOGY OF AGING (2004)
Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease
MH Mohajeri et al.
FEBS LETTERS (2004)
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides:: a brief history, the beginning and follow-ups to early studies
RA Skidgel et al.
PEPTIDES (2004)
Identification of cathepsin B as a mediator of neuronal death induced by Aβ-activated microglial cells using a functional genomics approach
L Gan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain
N Iwata et al.
JOURNAL OF NEUROSCIENCE (2004)
Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation
RT Liu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice
HM Tucker et al.
NEUROSCIENCE LETTERS (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Insulin-degrading enzyme in brain microvessels -: Proteolysis of amyloid β vasculotropic variants and reduced activity in cerebral amyloid angiopathy
L Morelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Microglial phagocytosis of fibrillar β-amyloid through a β1 integrin-dependent mechanism
J Koenigsknecht et al.
JOURNAL OF NEUROSCIENCE (2004)
Immunolocalisation of endothelin-1 in human brain
V Naidoo et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form
H Kanemitsu et al.
NEUROSCIENCE LETTERS (2003)
Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy
JM Lee et al.
ANNALS OF NEUROLOGY (2003)
Differential degradation of amyloid β genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme
L Morelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CD36 mediates the innate host response to β-amyloid
JB El Khoury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Pathogenic Aβ induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells
SS Jung et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo
BC Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
β-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes
S Deb et al.
BRAIN RESEARCH (2003)
Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease:: defining the perivascular route for the elimination of amyloid β from the human brain
SD Preston et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
F Bard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Alzheimer's disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme
EA Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon 4 allele
DG Cook et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention
B Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Microglia and inflammatory mechanisms in the clearance of amyloid β peptide
J Rogers et al.
GLIA (2002)
Declining expression of neprilysin in Alzheimer disease vasculature: Possible involvement in cerebral amyloid angiopathy
M Carpentier et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Deposition of Alzheimer's β-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
S Vogelgesang et al.
PHARMACOGENETICS (2002)
Aβ42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo
MH Mohajeri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
KN Dahlgren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Amyloid-β oligomers:: their production, toxicity and therapeutic inhibition
DM Walsh et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Biogenesis and metabolism of Alzheimer's disease Aβ amyloid peptides
G Evin et al.
PEPTIDES (2002)
Aβ-degrading endopeptidase, neprilysin, in mouse brain:: synaptic and axonal localization inversely correlating with Aβ pathology
S Fukami et al.
NEUROSCIENCE RESEARCH (2002)
β-amyloid catabolism:: roles for neprilysin (NEP) and other metallopeptidases?
JA Carson et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ);: Retards Aβ aggregation, deposition, fibril formation, and inhibits cytotoxicity.
JG Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia
DG Walker et al.
NEUROBIOLOGY OF AGING (2001)
Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease
J Rogers et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme
EA Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia
E Savaskan et al.
NEUROBIOLOGY OF AGING (2001)
Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases
K Shirotani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Immunohistochemical localization of neprilysin in the human cerebral cortex:: inverse association with vulnerability to amyloid β-protein (Aβ) deposition
H Akiyama et al.
BRAIN RESEARCH (2001)
Metabolic regulation of brain Aβ by neprilysin
N Iwata et al.
SCIENCE (2001)
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
T Wyss-Coray et al.
NATURE MEDICINE (2001)
β-Amyloid efflux mediated by p-glycoprotein
FC Lam et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Reduced neprilysin in high plaque areas of Alzheimer brain:: a possible relationship to deficient degradation of β-amyloid peptide
K Yasojima et al.
NEUROSCIENCE LETTERS (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Degradation of amylin by insulin-degrading enzyme
RG Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons
J Van Dorpe et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins
M Morita et al.
CELL STRUCTURE AND FUNCTION (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma:: Suppression leads to biochemical and pathological deposition
N Iwata et al.
NATURE MEDICINE (2000)
Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2
AP Davenport et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Share Paper
